GHIT Fund Announces USD 11.6 Million to Boost R&D for TB, Leishmaniasis and Malaria
The Global Health Innovative Technology (GHIT) Fund, a Japan-based international public-private partnership (PPP), has announced a total investment of approximately USD 11.6 million to support four new research and development (R&D) projects targeting tuberculosis (TB), neglected tropical diseases (NTDs) and malaria.
Malaria | 29/10/2025 | By Dineshwori
ICMR and CDSCO Release First Set of 39 Standard IVD Evaluation Protocols
Standard In-Vitro Diagnostic (IVD) Evaluation Protocols, jointly developed by ICMR and CDSCO, include protocols for performance evaluation of IVD kits used for detecting tuberculosis, malaria, dengue, chikungunya, Zika virus, typhoid fever, various respiratory viruses, Chandipura virus, and Nipah virus.
Malaria | 19/09/2025 | By Dineshwori | 208
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy